Skip to main content
logo
Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
12.81
-0.24 (-1.84%)
Apr 23, 2026, 4:00 PM EDT - Market closed

Entrada Therapeutics Revenue

In the year 2025, Entrada Therapeutics had annual revenue of $25.42M, down -87.94%. Entrada Therapeutics had revenue of $1.30M in the quarter ending December 31, 2025, a decrease of -96.53%.

Revenue (ttm)
$25.42M
Revenue Growth
-87.94%
P/S Ratio
18.14
Revenue / Employee
$167,243
Employees
152
Market Cap
461.16M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202525.42M-185.36M-87.94%
Dec 31, 2024210.78M81.77M63.38%
Dec 31, 2023129.01M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE205.07M
REGENXBIO170.44M
Ginkgo Bioworks Holdings170.16M
Assembly Biosciences72.30M
Invivyd53.43M
XOMA Royalty52.15M
Altimmune41.00K
Revenue Rankings

TRDA News

More News